Biofrontera AG (B8F):医療機器:M&Aディール及び事業提携情報

GlobalDataが発行した調査報告書(DATA904C7119)
◆英語タイトル:Biofrontera AG (B8F) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7119
◆発行会社(リサーチ会社):GlobalData
◆発行日:2018年10月
◆ページ数:38
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:ドイツ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Summary
Biofrontera AG (Biofrontera) is a biopharmaceutical company that develops and commercializes dermatological medications and medical cosmetics. The company’s products comprise Ameluz, BF-RhodoLED and Belixos. Its prescription drug Ameluz is used for the treatment of skin disease actinic keratosis. Biofrontera’s BF-RhodoLED is a lamp used for photodynamic therapy with LEDs emitting red light. Belixos is a cosmetic product,indicated for regenerative care of reddened and inflamed skin. Its Belixos line of products include Belixos creme, Belixos liquid, Belixos gel, Belixos to go and Belixos protect. The company sells products to wholesalers, physicians, clinics and licensing partners. Biofrontera is headquartered in Leverkusen, Germany.

Biofrontera AG (B8F) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Biofrontera AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Biofrontera AG, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Biofrontera AG, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Biofrontera AG, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Biofrontera AG, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Biofrontera AG, Medical Equipment, Deal Details 10
Private Equity 10
Deutsche Balaton to Acquire 14% Stake in Biofrontera 10
Equity Offering 11
Biofrontera Raises USD13 Million in Public Offering of ADS 11
Biofrontera Raises USD17 Million in Rights Offering of Shares 13
Biofrontera Secures USD22.2 Million in Financing 14
Biofrontera to Raise USD16.5 Million in Private Placement of Shares 15
Debt Offering 16
Biofrontera Raises USD5.5 Million in Private Placement of Bonds Due 2020 16
Biofrontera AG – Key Competitors 17
Biofrontera AG – Key Employees 18
Biofrontera AG – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 20
Financial Announcements 20
Oct 10, 2018: Biofrontera announces preliminary unaudited sales revenue for the first nine months of 2018 and increases revenue guidance 20
Sep 17, 2018: Biofrontera uses the long summer months to introduce daylight photodynamic therapy (PDT) with Ameluz in the EU 21
Aug 31, 2018: Biofrontera reports significant revenue growth for the first 6 months of 2018 22
Jul 05, 2018: Biofrontera: Sales revenue for Ameluz(R) doubled for the six-month period ended June 30, 2018 24
May 30, 2018: Biofrontera Announces First Quarter 2018 Financial Results 25
Apr 30, 2018: Biofrontera Announces Full Year 2017 Financial Results 27
Apr 12, 2018: Biofrontera announces preliminary unaudited sales revenues for the 1st Quarter 2018 30
Jan 22, 2018: Biofrontera Announces Preliminary Unaudited Full Year 2017 Revenue 31
Nov 27, 2017: Biofrontera Reports Financial Results for Third Quarter and First Nine Months of 2017 32
Nov 14, 2017: Biofrontera adjusts revenues and earnings forecast for the financial year 2017 34
Aug 31, 2017: Biofrontera Grows Revenues and Improves Financial Position in First Half 2017 35
Legal and Regulatory 37
Jul 12, 2018: Biofrontera: Biofrontera subsidiary files suit against DUSA Pharmaceuticals 37
Appendix 38
Methodology 38
About GlobalData 38
Contact Us 38
Disclaimer 38

List of Tables
Biofrontera AG, Medical Equipment, Key Facts, 2017 2
Biofrontera AG, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Biofrontera AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Biofrontera AG, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Biofrontera AG, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Biofrontera AG, Deals By Market, 2012 to YTD 2018 8
Biofrontera AG, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Deutsche Balaton to Acquire 14% Stake in Biofrontera 10
Biofrontera Raises USD13 Million in Public Offering of ADS 11
Biofrontera Raises USD17 Million in Rights Offering of Shares 13
Biofrontera Secures USD22.2 Million in Financing 14
Biofrontera to Raise USD16.5 Million in Private Placement of Shares 15
Biofrontera Raises USD5.5 Million in Private Placement of Bonds Due 2020 16
Biofrontera AG, Key Competitors 17
Biofrontera AG, Key Employees 18
Biofrontera AG, Subsidiaries 19

List of Figures
Biofrontera AG, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Biofrontera AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Biofrontera AG, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Biofrontera AG, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Biofrontera AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Biofrontera AG, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Biofrontera AG, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Biofrontera AG, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ Biofrontera AG (B8F):医療機器:M&Aディール及び事業提携情報(Biofrontera AG (B8F) - Medical Equipment - Deals and Alliances Profile)]についてメールでお問い合わせはこちらでお願いします。

◆H&Iグローバルリサーチのお客様(例)◆